Fairchem Organics Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/z2se7cp1vdrceeov8o03us9y.pdf

Key Takeaways


Dimer Acid: The Structural Disadvantage

Jariwala: "See, you need to understand, time and again we are seeing one thing, the raw material, that is vegetable oil, in India we are getting imported at 16.5% import duty, and based on that our raw material is also priced accordingly, and against that if you import dimer fatty acid, it is carrying import duty of 7.5%. So, effectively we are sufferers, because the raw material is having higher import duty, but the finished product is having lower import duty."

Export Recovery: The Policy Bet

Jariwala: "For every 100 kg of soybean oil, 1% of our raw material is getting generated. So, as a company, we cannot take a risk of, to get 1% material, take a risk of 99% of vegetable oil, which is a commodity, where prices go up and down every moment. So, that is something we will not dabble ourselves. It is not our core competency."

Paint Sector & Domestic Demand


Cost & Margin Initiatives


Capital Allocation & Capacity


Guidance & Commitments

CommitmentSpecificsTimeline
Volume and value growthEvery quarter will see volume and value growth from hereStarting Q4 FY26
EBITDA margin improvementGradual improvement, with better numbers visibleH2 FY27
Isosteric acid export recoveryUS customers re-engaging; "things should be back on track"Within six months
Chinese export incentive removalIf dimer falls under 700-chemical list, 12-13% price hike from Chinese players flows to EBITDAApril 1, 2026
New product equipment productionInitial small capacity goes into productionQ3 FY27
Alternative raw material impactMaterial impacts from trials expectedQ2/Q3 FY27
Animal feed plant startPlant ready; awaiting GMP certificationUpon certification receipt
Export share targetMove from 9% to as high as 50% exports; no CAPEX neededNo date given
Previous guidance withdrawn₹1,000 crore revenue / 23% EBITDA margin guidance will not be reinstatedN/A

Key Metrics

MetricQ3 FY26
Revenue from operations₹100 cr, -12% YoY
9M FY26 revenue from operations₹343 cr, -18% YoY
EBITDA₹4 cr, margin 4.2%
9M FY26 EBITDA₹14 cr, -65% YoY, margin 3.97%
Adjusted PAT (excl. exceptional items)₹60 lakhs, margin 0.6%
9M FY26 PAT before exceptional items₹2.5 cr, margin 0.73%
Exceptional items₹88 lakhs, new Labor Code implementation
Volume throughput9,850 tonnes
Domestic revenue share91% of total revenue
Export revenue share9% of total revenue, target to reach 50%
Capacity utilization~55%
Raw material import duty~16.5%
Dimer acid finished product import duty7.5%
Tocopherol businessZero for two quarters, 100% exported to US
Revenue decline from FY22 peak~₹200 cr reduction, from ~₹650 cr to ~₹450 cr (past 12 months)
Price decline from FY22 peak10% to 15%